文献速递妇科

接受睾酮治疗患者行性别肯定子宫切除术的手术并发症、阴道出血及实践考量

Operative Complications, Vaginal Bleeding, and Practice Considerations for Patients on Testosterone Undergoing Gender-Affirming Hysterectomy.
PubMed 文献 · J Minim Invasive Gynecol · 2024-05-31

回顾性队列研究比较使用睾酮的跨性别患者与对照组行微创性别肯定子宫切除术的手术并发症和医疗资源使用。睾酮组术中会阴裂伤需修补风险增加(RR 3.3,95%CI 1.03-10.5),通过电子病历消息或电话报告阴道出血更多(RR 1.74,95%CI 1.1-2.7),术后阴道雌激素使用更频繁(7例[8.0%] vs 4例[1.7%],P=0.01)。

要点

  • 睾酮组术中会阴裂伤需修补风险增加(RR 3.3,95%CI 1.03-10.5)。
  • 睾酮组通过电子病历消息或电话报告阴道出血更多(RR 1.74,95%CI 1.1-2.7)。
  • 睾酮组术后阴道雌激素使用更频繁(7例[8.0%] vs 4例[1.7%],P=0.01)。

核心结论

  • 术前使用睾酮可能增加术中阴道裂伤需修补的风险。
  • 睾酮使用也与通过电子病历消息、电话和门诊就诊报告阴道出血增加相关。
  • 这些结果为术前咨询提供新证据,并支持性别肯定子宫切除术安全性的现有证据。

研究设计与样本

  • 回顾性队列研究,纳入2014年1月至2022年12月期间接受良性微创子宫切除术(伴或不伴卵巢切除术)的18至55岁患者。
  • 睾酮使用组为性别认同为男性、跨性别男性、性别酷儿或非二元性别且术前有记录睾酮使用的患者(n=88)。
  • 对照组为性别认同为女性、性别酷儿或非二元性别且无记录睾酮使用的患者(n=242)。
  • 通过手术记录收集术中并发症信息,并通过术后90天收集术后并发症、电子病历消息、电话、急诊就诊和门诊就诊信息。

主要发现

  • 睾酮使用组患者更年轻、体重指数更低、美国麻醉医师协会分级更低,且更可能未产。
  • 睾酮使用的中位时间为2.5年(1.5-5.0)。
  • 睾酮组术中会阴裂伤需修补风险增加(RR 3.3,95%CI 1.03-10.5)。
  • 睾酮组通过电子病历消息或电话报告阴道出血的患者更多(RR 1.74,95%CI 1.1-2.7)。
  • 急诊就诊原因无差异;术后门诊开始的阴道雌激素使用在睾酮组更频繁(7例[8.0%] vs 4例[1.7%],P=0.01)。

临床怎么用

  • 作者认为术前使用睾酮可能增加术中阴道裂伤需修补的风险,并与阴道出血报告增加相关,这些结果可用于术前咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To evaluate operative complications and healthcare utilization in transgender patients on testosterone undergoing minimally invasive gender-affirming hysterectomy compared to control patients. DESIGN: We performed a retrospective cohort study. Operative reports were used to gather information on intraoperative complications. We collected information on postoperative complications, electronic medical record (EMR) messages, phone calls, emergency department utilization, and clinic visits through a 90-day postoperative period. Healthcare utilization reasons were categorized as vaginal bleeding, pain, vaginal discharge, dysuria, urinary retention, bowel concern, incision concern, or other. SETTING: Tertiary care academic medical center. PATIENTS: Patients aged 18 to 55 who underwent a benign minimally invasive hysterectomy with or without oophorectomy performed between January 2014 and December 2022. The testosterone-using cohort consisted of patients who had a gender identity of male, transgender male, genderqueer, or nonbinary with documented testosterone use prior to surgery (n = 88). The control cohort consisted of patients who identified as female, genderqueer, or nonbinary with no documented testosterone use (n = 242). INTERVENTIONS: Not applicable. MEASUREMENTS AND MAIN RESULTS: Patients using testosterone were younger, had a lower body mass index, lower American Society of Anesthesiologists class, and were more likely to be nulliparous. The median time patients used testosterone was 2.5 years (1.5-5.0). Patients on testosterone are at increased risk of intraoperative perineal lacerations requiring repair (RR 3.3, CI 95% [1.03-10.5]). A higher number of patients on testosterone reported vaginal bleeding via EMR message or phone call (RR 1.74 CI 95% [1.1-2.7]) compared to controls. No difference in reasons for emergency department visits was noted. The use of postoperative vaginal estrogen started at the postoperative visit was more frequent in the testosterone-using patients (7 [8.0%] vs 4 [1.7%], p = .01). CONCLUSION: This study demonstrates that testosterone use preoperatively may increase risk of intraoperative vaginal laceration requiring repair. Testosterone use also correlates with increased reports of vaginal bleeding through EMR message, phone call, and clinic visit. These results contribute new evidence to include in preoperative counseling and support existing evidence surrounding the safety of gender-affirming hysterectomy.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Pando C, Gerlach LR, Challa SA, et al. Operative Complications, Vaginal Bleeding, and Practice Considerations for Patients on Testosterone Undergoing Gender-Affirming Hysterectomy. J Minim Invasive Gynecol. 2024. PMID: 38823625. doi:10.1016/j.jmig.2024.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。